Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MULTIPLE SCLEROSIS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT04925557
What this trial is testing

Study to Assess the Efficacy of Mayzent on Microglia in Secondary Progressive Multiple Sclerosis

Who this might be right for
Secondary-progressive Multiple Sclerosis
State University of New York at Buffalo 8
Not applicableStudy completedNCT01971294
What this trial is testing

Lower Urinary Tract Symptoms in Systemic Sclerosis

Who this might be right for
Urinary SymptomsSystemic Sclerosis
University Hospital, Geneva 334
Post-approval studies (Phase 4)Study completedNCT02255656
What this trial is testing

Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Genzyme, a Sanofi Company 1,062
Post-approval studies (Phase 4)Ended earlyNCT01005095
What this trial is testing

The Effects of Interferon Beta Combined With Vitamin D on Relapsing Remitting Multiple Sclerosis Patients

Who this might be right for
MULTIPLE SCLEROSIS
Carmel Medical Center 45
Not applicableStudy completedNCT06468241
What this trial is testing

The Effect of Music and Progressive Relaxation Exercise on Fatigue and Sleep in Multiple Sclerosis

Who this might be right for
Multiple SclerosisFatigueSleep
Ondokuz Mayıs University 30
Post-approval studies (Phase 4)Study completedNCT01968902
What this trial is testing

Safety of Xeomin for Lower Limb Spasticity in Multiple Sclerosis Patients

Who this might be right for
Muscle SpasticityMultiple Sclerosis
Multiple Sclerosis Center of Northeastern New York 27
Early research (Phase 1)Study completedNCT02583594
What this trial is testing

Characterize Subcutaneous or Intravenous Alemtuzumab in Patients With Progressive Multiple Sclerosis

Who this might be right for
Progressive Multiple Sclerosis
Genzyme, a Sanofi Company 24
Not applicableEnded earlyNCT01723631
What this trial is testing

Analyze the Myelin-TRAP as Diagnostic Tool in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Nantes University Hospital 189
Testing effectiveness (Phase 2)Ended earlyNCT01428505
What this trial is testing

[18F]PBR111 and Microglial Activation in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
GlaxoSmithKline 50
Large-scale testing (Phase 3)Study completedNCT02792231
What this trial is testing

Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.

Who this might be right for
Relapsing Multiple Scelrosis
Novartis Pharmaceuticals 955
Not applicableUnknownNCT03186612
What this trial is testing

Virtual Reality and Manual Dexterity in in Patients With Multiple Sclerosis

Who this might be right for
Multiple SclerosisPhysical ActivityUpper Limb+2 more
Universidad Rey Juan Carlos 26
Not applicableWithdrawnNCT02889419
What this trial is testing

Benefits Evaluation of Selfia® Adapted Underwear for MS Patients Performing Self-catheterization

Who this might be right for
Multiple Sclerosis
Lille Catholic University
Testing effectiveness (Phase 2)Enrolling By InvitationNCT05805839
What this trial is testing

Imaging in Demyelinating Diseases

Who this might be right for
Multiple SclerosisInflammatory Demyelinating Disease
Mayo Clinic 200
Not applicableLooking for participantsNCT05124600
What this trial is testing

An Individualized-health eLibrary App for People With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University of Illinois at Urbana-Champaign 60
Testing effectiveness (Phase 2)Ended earlyNCT02104011
What this trial is testing

Treatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockers

Who this might be right for
Renal AngiomyolipomasTuberous Sclerosis
University Hospital, Bordeaux 2
Not applicableStudy completedNCT01931644
What this trial is testing

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Who this might be right for
All Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more
Sanguine Biosciences 17,667
Post-approval studies (Phase 4)Active Not RecruitingNCT05090371
What this trial is testing

Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Novartis Pharmaceuticals 136
Large-scale testing (Phase 3)Study completedNCT00370071
What this trial is testing

Open Label Study to Evaluate Effect, Safety and Tolerability of Betaferon Standard Dose of 250µg in Patients of Chinese Origin With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Bayer 39
Not applicableStudy completedNCT07504783
What this trial is testing

Evaluate the Real-world Experience and Satisfaction Associated With Ofatumumab

Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 261
Early research (Phase 1)Study completedNCT01764737
What this trial is testing

Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS

Who this might be right for
Multiple Sclerosis
Vaccinex Inc. 50
Next Page